Romanel, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 4.468
EU - Europa 857
AS - Asia 604
OC - Oceania 4
SA - Sud America 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.943
Nazione #
US - Stati Uniti d'America 4.454
SG - Singapore 311
IT - Italia 298
CN - Cina 139
SE - Svezia 105
FI - Finlandia 89
DE - Germania 87
UA - Ucraina 84
GB - Regno Unito 74
VN - Vietnam 53
ID - Indonesia 48
BG - Bulgaria 30
JO - Giordania 19
RU - Federazione Russa 19
CA - Canada 13
CZ - Repubblica Ceca 13
IN - India 13
IE - Irlanda 9
ES - Italia 8
NL - Olanda 7
AT - Austria 5
JP - Giappone 5
NO - Norvegia 4
CH - Svizzera 3
DZ - Algeria 3
KR - Corea 3
LT - Lituania 3
LU - Lussemburgo 3
AU - Australia 2
BE - Belgio 2
CL - Cile 2
EU - Europa 2
FR - Francia 2
HK - Hong Kong 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
PK - Pakistan 1
RS - Serbia 1
TH - Thailandia 1
TJ - Tagikistan 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 5.943
Città #
Fairfield 733
Chandler 530
Ashburn 388
Woodbridge 333
Seattle 294
Singapore 246
Houston 243
Cambridge 227
Wilmington 215
Jacksonville 184
Columbus 159
San Mateo 148
Ann Arbor 142
Princeton 111
Trento 89
New York 71
Helsinki 50
Como 49
Jakarta 48
Beijing 45
Boardman 45
Dong Ket 40
San Diego 36
Dearborn 33
Sofia 30
Bremen 24
London 22
San Paolo di Civitate 17
Tolentino 17
Los Angeles 15
Moscow 15
Lawrence 13
Santa Clara 13
Brno 11
Rome 11
Toronto 10
Andover 9
Munich 9
Norwalk 9
Washington 9
Altamura 8
Dallas 8
Pune 8
Riva Del Garda 8
Shanghai 8
Bend 7
Bonndorf 7
Castello Molina di Fiemme 7
Falls Church 7
Lappeenranta 7
Bassano del Grappa 6
Council Bluffs 6
Fremont 6
Lavis 6
Milan 6
Bolzano 5
Padova 5
Verona 5
Vienna 5
Amsterdam 4
Arco 4
Barcelona 4
Cagliari 4
Oslo 4
Phoenix 4
Annaba 3
Chiswick 3
Dresden 3
Frankfurt am Main 3
Hefei 3
Hesperange 3
Ottawa 3
San Francisco 3
St Louis 3
Stockholm 3
Tokai 3
Vicenza 3
Acton 2
Auckland 2
Augusta 2
Changsha 2
Chicago 2
Dongguan 2
Dottingen 2
Dublin 2
Elda 2
Guangzhou 2
Hong Kong 2
Jinan 2
Laurel 2
Leawood 2
Nanjing 2
Naples 2
Newark 2
Peschiera del Garda 2
Prescot 2
Riga 2
Romainville 2
San Marcos 2
Southwark 2
Totale 4.924
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 261
Inherited determinants of early recurrent somatic mutations in prostate cancer 247
EthSEQ: ethnicity annotation from whole exome sequencing data 191
A highly specific SpCas9 variant is identified by in vivo screening in yeast 177
ASEQ: Fast allele-specific studies from next-generation sequencing data 157
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 146
Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma 129
Estimating the divisibility of complex biological networks by sparseness indices 121
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 117
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 117
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 113
Exploring functionally annotated transcriptional consensus regulatory elements with CONREL 112
In-silico identification and functional validation of allele-dependent AR enhancers 108
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 105
Ancestry-specific predisposing germline variants in cancer 104
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 104
Modelling self-assembly in BlenX 103
The Beta Workbench: a computational tool to study the dynamics of biological systems 102
Exploiting non-Markovian Bio-Processes 101
Punctuated evolution of prostate cancer genomes. 100
Evolving BlenX programs to simulate the evolution of biological networks 100
Modelling and simulation of biological processes in BlenX 98
A Formal and Integrated Framework to Simulate Evolution of Biological Pathways 98
Tumor clone dynamics in lethal prostate cancer 97
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care 97
Transcriptional regulation is a major controller of cell cycle transition dynamics 96
Plasma AR and abiraterone-resistant prostate cancer 95
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 94
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 94
BlenX Static and Dynamic Semantics 93
Programming Biology in BlenX 91
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 87
Unraveling the clonal hierarchy of somatic genomic aberrations 86
Modeling Static Biological Compartments with Beta-binders 83
One-shot analysis of translated mammalian lncrnas with aharibo 82
ABEMUS: platform specific and data informed detection of somatic SNVs in cfDNA 80
On the Decidability and Complexity of the Structural Congruence for Beta-binders 75
On the Computational Power of BlenX 74
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 73
The Decidability of the Structural Congruence for Beta-binders 70
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response 70
On the impact of discreteness and abstractions on modelling noise in gene regulatory networks 68
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 66
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes 64
The BlenX Language: A Tutorial 63
Effective Index: A Formal Measure of Drug Effects 61
Simple methods for peak and valley detection in time series microrray data 60
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer 58
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer 58
Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence 58
BetaWB: modelling and simulating biological processes 55
Inherited variant in NFκB‐1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding 54
Analytical protocol to identify local ancestry-associated molecular features in cancer 53
TranSNPs: A class of functional SNPs affecting mRNA translation potential revealed by fraction-based allelic imbalance 53
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 53
Allele-specific expression analysis in cancer using next-generation sequencing data 52
Polympact: Exploring functional relations among common human genetic variants 52
Self-assembly processes with cooperativity 48
Towards a process calculi approach to study the evolution of biological networks 48
A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness 47
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation 47
Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster 42
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 35
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice 29
Rarγ -Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer 28
Germline determinants of aberrant signaling pathways in cancer 28
Simple methods for peak and valley detection in time series microarray data 24
Dynamic Biological Modelling: a language-based approach 24
Effective Index: A Formal Measure of Drug Effects 23
A Formal and Integrated Framework to Simulate Evolution of Biological Pathways 22
SpikeFlow: automated and flexible analysis of ChIP-Seq data with spike-in control 21
The BlenX Language: A Tutorial 21
Analysis of Genetic Ancestry from NGS Data Using EthSEQ 20
Synggen: fast and data-driven generation of synthetic heterogeneous NGS cancer data 20
On the Computational Power of BlenX 19
Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations 18
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 18
On the Decidability and Complexity of the Structural Congruence for Beta-binders 17
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers 17
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay 16
The Beta Workbench 15
Simulation of non-Markovian Processes in BlenX 15
Analysis of germline-driven ancestry-associated gene expression in cancers 13
Beta-binders with Static Compartments 11
Totale 6.162
Categoria #
all - tutte 30.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.740
Totale 32.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020771 0 0 0 0 93 72 103 85 139 170 36 73
2020/20211.366 11 219 105 195 117 105 87 88 71 105 137 126
2021/2022914 77 110 10 42 31 34 17 178 60 90 92 173
2022/20231.072 157 155 14 186 87 148 10 86 122 15 53 39
2023/2024573 25 34 34 11 58 154 33 56 23 45 11 89
2024/2025745 26 20 179 431 89 0 0 0 0 0 0 0
Totale 6.162